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Muscle and lower motor neuron diseases share a common de-
nominator of perturbed muscle function, most often related to 
wasting and weakness of muscles. This leads to a number of 
challenges, such as restricted mobility and respiratory difficul-
ties. Currently there is no cure for these diseases. The purpose 
of this review is to present research that examines the effects of 
exercise in muscle and lower motor neuron diseases. Evidence 
indicates that moderate intensity aerobic- and strength exercise 
is advantageous for patients with muscle diseases, without caus-
ing harmful exercise-induced muscle damage. On the contrary, 
motor neuron diseases show a rather blunted response from ex-
ercise training. High-intensity training is a modality that seems 
safe and a promising exercise method, which may circumvent 
neural fatigue and provide effect to patients with motor neuron 
disease. Although we have come far in changing the view on 
exercise therapy in neuromuscular diseases to a positive one, 
much knowledge is still needed on what dose of time, intensity 
and duration should be implemented for different disease and 
how we should provide exercise therapy to very weak, non-am-
bulatory and wheelchair bound patients. 
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Background
Muscle and lower motor neuron diseases encompass 
a large number of conditions with a common denomina-
tor of muscle weakness and wasting in most cases, which 
may lead to a number of challenges, such as fatigue, re-
stricted mobility, and respiratory difficulties that impact a 
person’s quality of life (1). Currently, treatment options 
for these diseases are scarce, and patients rely on support-
ive disease management that may contribute to enhance 
quality of life by improving physical function and possi-
bly stabilizing or slowing down disease progression. 
For a long time, physical exercise was considered del-
eterious for patients with muscle diseases, the notion being 
that contractions in the pathological muscle would accel-
erate the disease process. This notion was supported by 
experiments in the mdx mouse model of Duchenne muscu-
lar dystrophy that showed signs of damage after exercise. 
However, the types of exercise used were highly unphysi-
ological as they involved eccentric exercise and electrical 
stimulation of muscle (2, 3) types of exercise that would 
also induce muscle damage in a healthy individual.
Exercise is physical activity that is planned, structured, 
and repetitive for the purpose of conditioning any part of 
the body. The general population is encouraged to exercise 
because of its great health benefits, and it’s importance as 
a means of physical rehabilitation is also widely acknowl-
edged (4). Lack of exercise, regardless of condition, leads 
to a variety of changes in the body. The heart’s ability to 
pump blood efficiently, aerobic capacity, and muscles’ ca-
pacity to process oxygen declines, which ultimately leads 
to decreased endurance, muscle weakness, and fatigue (4), 
as well as numerous lifestyle-related diseases. Patients 
with muscle and lower motor neuron diseases are more 
prone to developing disorders associated with a sedentary 
lifestyle, such as obesity and metabolic syndrome due to 
restricted mobility  (5-7). Currently there are no specific 
guidelines about the type or intensity of exercise recom-
mended to these patients. One of the challenges health care 
professionals often face is the question of how much, and 
what type of exercise should patients engage in. None-
theless, the body of evidence favoring exercise training 
in patients with muscle and lower motor neuron diseases 
has increased substantially in the last two decades, and the 
purpose of this review is to present the current evidence for 
physical conditioning in these disease groups.
Methods
A literature search on PubMed, using key words 
“Limb girdle muscular dystrophy”, “Becker muscular 
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dystrophy”, “facioscapulohumeral muscular dystrophy”, 
“myotonic muscular dystrophy”, “McArdle disease”, 
“Pompe disease”, “mitochondrial myopathy”, “spinal 
and bulbar muscular atrophy”, “spinal muscular atrophy” 
combined with key words “exercise”, “training”, “physi-
cal activity”, “resistance training”, “resistance exercise”, 
“strength training”, “strength exercise”, “aerobic train-
ing”, “aerobic exercise”, “endurance training”, “endur-
ance exercise”, was performed from January 2018 to July 
2019. Article selection was based on 1) studies assessing 
the effects of exercise on humans with these diseases, 
2) articles that included a well described diagnosis of a 
muscle or motor neuron disease, and 3) articles that pro-
vided a well-described exercise intervention. We includ-
ed randomized controlled trials (RCT), cohorts, and case 
reports. Articles were excluded if they did not include an 
exercise intervention, lacked intervention description, or 
were animal studies. In addition, articles exclusively fo-
cusing on training of respiratory muscles were also ex-
cluded. Using these inclusion and exclusion criteria’s, 
fifty articles were chosen to form the basis for this review. 
Experience with exercise training 
in individuals with muscle and 
lower motor neuron diseases
Muscular dystrophies
Limb girdle muscular dystrophy
Aerobic exercise
More than 32 different kinds of Limb girdle muscular 
dystrophies (LGMD) are known, and exercise has only 
been studied in a few of the disorders. Aerobic exercise 
has been studied in smaller cohorts of LGMD2I and LG-
MD2L. Patients with LGMD2L completed a 10-week 
moderate aerobic training program (8). The six patients 
completing the training experienced improvements in fit-
ness, functional capacity, and lower limb strength. No ad-
verse events were reported. Moderate endurance training 
also improved aerobic capacity in 9 patients with LGM-
D2I (9), and patients expressed feeling an improvement 
in physical function. There was no significant increase in 
training-induced creatine kinase (CK) levels. Moderate 
aerobic training seems to provide patients with LGMD 
better physical function and appears safe, but longer-term 
studies are needed.
Strength exercise 
Low- and high-intensity resistance training in patients 
with LGMD2A and LGMD2I was found to be generally 
well tolerated (10). Two LGMD2A patients were excluded 
from the high resistance training group due to training-in-
duced CK elevation. Resistance training could potentially 
be a beneficial part of a functional rehabilitation program, 
but should be carefully monitored for muscle damage.
Assisted exercise 
Sczesny-Kaiser et al. (11) performed a treadmill ex-
ercise study using hybrid assistive limb (HAL®) in three 
LGMD patients; LGMD2A, LGMD2I, and a LGMD of 
unknown subtype. HAL® is a powered exoskeleton and 
is used during exercise to enhance physical capabilities 
in people with disabilities. Physical endurance improved 
and no adverse events were reported. Despite a small sam-
ple size, the results are interesting, and the technology al-
lows health care professionals to train very weak patients. 
Anti-gravity training improved functional ability in weak 
patients with LGMD2I  (12), and enhanced lower limb 
strength and walking distance (13). Both studies were safe 
and well tolerated and plasma CK levels did not indicate 
any exercise-induced muscle damage. Bodyweight-sup-
ported training allows patients to work at a certain per-
centage of bodyweight due to off-lifting of weight by 
slings or air pressure making it possible for weak patients 
to exercise. However, it is costly and cannot be performed 
in patients’ habitual environment. 
Other exercise modalities
Effect of electrical stimulation therapy and exer-
cise therapy in patients with LGMD was investigated by 
Kılınç et al.  (14). In the electrical stimulation therapy 
group, stimulation was applied bilaterally on the deltoid 
and quadriceps muscles using high voltage-pulsed galvan-
ic stimulation with a pulse frequency of 50Hz for optimal 
contractions. Duty cycle was set at 5 seconds on and 10 
seconds off, during 10 minutes of stimulation of each mus-
cle. The exercise therapy group consisted of bilateral pro-
gressive resistance exercise of the deltoid and quadriceps 
muscles. The electrical stimulation therapy group gained 
muscle strength and physical function improved. The ex-
ercise therapy group had similar improvements. This study 
provides important information on the role of electrical 
stimulation therapy and exercise therapy for health care 
professionals working in rehabilitation clinics. 
Intervention specifications for LGMDs are presented 
in Table 1.
Becker muscular dystrophy 
Aerobic exercise
Moderate cycle training improves aerobic capacity 
and strength in patients with Becker muscular dystrophy 
(BMD) after three months of exercise, and these im-
provements are maintained after additional 9 months of 
training, without any rise in CK level (15). Enhancement 
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in muscle strength and physical function after treadmill 
training were also reported in a case study (16). Interest-
ingly, an elevation in CK level was observed, indicating 
that rehabilitative intervention should be carefully mon-
itored to avoid harmful exercise-induced side effects de-
spite functional improvement.
 
Strength exercise 
In patients with BMD, low- and high-intensity resis-
tance training was generally well tolerated and patients 
showed an increase in endurance and arm strength (10), 
without signs of muscle damage. 
Assisted exercise 
Anti-gravity training resulted in improved physical 
function and functional ability  (12), and another study 
found that bodyweight-supported training improved low-
er limb strength and walking distance (13). In both stud-
ies, exercise was well tolerated and CK levels did not in-
dicate any exercise-induced muscle damage. Intervention 
specifications for BMD are presented in Table 2.
Facioscapulohumeral muscular dystrophy
Aerobic exercise
Moderate aerobic exercise improved self-reported 
changes in activities of daily living (ADL) in a cohort of 
8 patients with facioscapulohumeral muscular dystrophy 
(FSHD) (17). Similar improvements were discovered in 
a randomized, double-blind, placebo-controlled parallel 
study where the investigators found improvements in 
fitness, self-assessed physical capacity, and health  (18). 
Table 1. A representation of exercise interventions done in LGMD 2A, LGMD 2L, and LGMD 2I. Number in parenthesis 
represents the article reference.
Exercise 
mode/N
Duration Frequency Intensity Improved outcome
Cycling
N = 6
(8)
10 weeks 3 days/week 
30 min/session
70% of VO2max VO2max, lower limb 
strength, 6MWT, 5 x STS, 
6SST.
Cycling
N = 9
(9)
12 weeks 50 sessions in 
total
30 min/session
65% of VO2max VO2max, workload, 
self-reported physical 
endurance, lower limb 
muscle strength, and 
walking distance.
Strength: 
LOIT
N = 6
HIT
N = 3
Control group 
N = 6
(10)
6 months
3 months
3 days/week
Twice at home 
and once at lab
3 days/week at 
lab
Low intensity
Knee extension, Elbow flexion
40% of 1RM, increase with 5% every 
other week
3 sets x 12-15 reps
High intensity:
Knee extension, Elbow flexion
Wrist flexion & extension
Ankle plantar flexion
70-85% of 1RM 3 x 8-12 reps for 1 
month
80-90% of 1RM 3 x 6-10 reps for 2 
months
85-92% 3 x 8-4 reps for 3 months
Bicep strength and 
endurance, wrist 
flexion, extension, and 
endurance
Treadmill 
training using 
HAL®
N = 3
(11)
8 weeks
F/U at 6 
weeks post 
intervention
3 days/week
Maximum of 30 
minutes/session
Velocity of treadmill was set 
individually 
Up to 50% body weight support
10MWT, 6MWT, and TUG 
u
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Voet et al examined the effects of moderate aerobic exer-
cise therapy and cognitive behavioral therapy on fatigue, 
strength, and exercise tolerance. One group underwent 
cycling and one group underwent cognitive behavioral 
therapy comprising of 6 modules directed towards insuffi-
cient coping with the disease. After a 12-week follow-up, 
the majority of patients continued their level of activity 
and the beneficial effects remained (19). This study pro-
vides valuable information about the impact of physical 
activity on fatigue. Fatigue can have a detrimental effect 
on quality of life, and it is substantial to apply appropri-
ate management. Safety and efficacy of a 6-month home-
based exercise program was assessed in a multicenter 
randomized controlled trial (20). The results showed an 
improvement in aerobic capacity, strength, and functional 
capacity. Exercise did not elevate CK levels in any of the 
presented studies. Health care professionals are encour-
aged to promote regular exercise compatible with FSHD 
patients’ daily professional and social life. 
Strength exercise
Strength training in patients with FSHD was examined 
by van der Kooi et al in a randomized, double-blind, pla-
cebo-controlled trial (21). Training group consisted of 34 
patients and a non-training control group consisted of 31 
patients. At week 26 during the intervention, albuterol was 
added. Some improvements in strength were observed in 
the training group and any training-induced muscle fatigue 
that occurred lasted less than an hour, and patients were 
able to carry out their habitual ADL. Of the 34 trained pa-
tients, 19 patients complained of neck and shoulder pain 
after the intervention. Plasma CK levels were not reported. 
The authors determined the training to be generally well 
tolerated and found no enhancing effects of albuterol. The 
number of patients reporting pain in neck and shoulder is 
great and the tolerability to strength training should be ex-
plored further.
Other exercise modalities 
Andersen et al.  (22) investigated the effects of super-
vised high-intensity training (HIT) in an RCT. Fitness im-
proved and CK measurements did not indicate any muscle 
damage during and post training. The majority of patients 
preferred HIT over moderate-intensity training. High-inten-
Exercise 
mode/N
Duration Frequency Intensity Improved outcome
Anti-gravity: 
N = 3
(12)
10 weeks of 
control period
10 weeks of 
training 
3 days/week
40 min/session
70-80% of maximum heart rate 
(HRmax)
Run/walk, jogging, and high knee lift 
12 reps of squats and lunges 
15-20 reps of calf raise
6MWT and dynamic 
balance
Bodyweight 
supported:
N = 3
(13)
10-week 
control period 
10 weeks of 
training 
3 days/week
40 min/session
70-80% of HRmax 
Closed-kinetic-chain strength 
exercises: squats, calf raises, and 
lunges
Aerobic: 
Walk/run, jogging
in place, or high knee-lift
Closed kinetic chain leg 
strength and training 
distance 
Electrical
stimulation 
N = 11
Strength
N = 13
(14)
8 weeks 3 days/week Shoulder abduction
Knee extension 
25% 1RM, 2 sets x10 reps
30% 1RM, 3 sets x 10 reps
35% 1RM, 3 sets x 10 reps
50% 1RM, 3 sets x 10 reps
Monophasic wave type. Surface 
electrodes. Pulse frequency 50Hz, 
voltage output 0-500 V, pulse 
duration 200 μs, duty cycle 5:10, 10 
minutes of stimulation
Strength, VAS, climb 8 
steps, 10MWT, dressing 
with t-shirt, endurance 
(number of reps per 
minute), and modified 
Lawton ADL.
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sity training may be a good option for patients struggling 
with fatigue. Neuromuscular electrical stimulation (NMES) 
is passive muscular training that can easily be adapted in the 
clinic and may be advantageous for very weak patients. Col-
son et al. (23) studied the safety and efficacy of NMES and 
found that the treatment was safe and well tolerated. Patients 
reported a reduction in pain, fatigue, and an increase in func-
tional capacity and strength. In addition, patients expressed 
feeling a positive effect on ADL. There was no significant 
CK level elevation during the intervention. 
Intervention specifications for FSHD are presented in 
Table 3.
Myotonic muscular dystrophy
Aerobic exercise
Ørngreen et al.  (24) studied the effects of aerobic 
training. Twelve of the 17 patients completed the study, 
five patients discontinued due to low compliance, and 
nine adhered adequately to the training protocol. Most 
patients reported beneficial changes in ADL and fitness 
Table 2. A representation of exercise interventions done in BMD. Number in parenthesis represents the article refer-
ence.
Exercise 
mode/N
Duration Frequency Intensity Improved outcome
Cycling
N = 11
Control group 
N = 7
(15)
12 weeks
12 months 
F/U
50 sessions in 
total 
30 min/
session
65% of VO2max VO2max, workload, hip 
abduction, and ankle 
plantar flexion and 
dorsiflexion
Treadmill 
N = 1
(16)
4 weeks 3 days/week
20 min/
session
65-80% HRmax Lower limb strength, 
TUG, 10MWT, and 
6MWT
Strength: 
LOIT
N = 2
HIT
N = 1
Control group 
N = 6
(10)
6 months
3 months
LOIT
3 days/week
Twice at 
home and 
once at lab
HIT
3 days/week 
at lab
Low intensity:
Knee extension, Elbow flexion
40% of 1RM, increase with 5% every other 
week
3 sets x 12-15 reps 
High intensity:
Knee extension, Elbow flexion
Wrist flexion & extension
Ankle plantar flexion
70-85% of 1RM 3 sets x 8-12 reps, month 
1
80-90% of 1RM 3 sets x 6-10 reps, month 
2
85-92% 3 sets x 8-4 reps, month 3
Bicep strength and 
endurance, wrist 
flexion, extension, and 
endurance
Anti-gravity: 
N = 5
(12)
10 weeks 
of control 
period
10 weeks 
of training 
intervention
3 days/week
40 min/
session
70-80% of maximum heart rate (HRmax) 
Run/walk, jogging, and high knee lift
12 reps of squats and lunges 
15-20 reps of calf raise
6MWT and dynamic 
balance
Bodyweight 
supported:
N = 5
(13)
10 weeks 
control 
period 
10 weeks 
of training 
intervention
3 days/week
40 min/
session
70-80% of HRmax 
Closed-kinetic-chain strength exercises: 
squats, calf raises, and lunges
Aerobic: 
Walk/run, jogging
in place, or high knee-lift 
Closed kinetic chain leg 
strength and training 
distance 
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improved after the training. Plasma CK levels did not in-
crease, but one patient reported a worsening of fatigue.
Strength exercise
The effect of strength training was first reported in 
1993, where modest strength improvements were ob-
served after 12 weeks of exercise (25). Tollbäck et al. (26) 
also found improvements in strength after training for 12 
weeks. Two patients dropped out for personal reasons and 
one dropped out due to severe back pain. No other adverse 
events were reported by the authors in the two studies. A 
study reported in 1995 (27) and another in 1999 (28) that 
strength training was safe and well tolerated, but no ap-
parent improvements were observed, neither any adverse 
events nor deterioration was reported. The absence of any 
prominent changes differs from previous studies (25, 26). 
One explanation could be that the patients exercised at 
home, which may influence the validity of their report-
ing and compliance or the effect of exercise was assessed 
with unfitting outcome measures.
Other exercise modalities
Cudia et al investigated the effects of functional elec-
trical stimulation induced cycling (29) and compared the 
intervention with strength and aerobic training. Muscle 
strength and walking distance improved. Improvements 
were also observed in the strength and aerobic group and 
no adverse events were reported. Fatigue can limit every-
day activities and adherence to exercise in these patients, 
and a reduction in treatment time, could possibly improve 
patient compliance. 
Patients with myotonic muscular dystrophy (DM) of-
ten face challenges with impaired hand function. Aldehag 
et al. (30) investigated the effects of hand training with a 
silicone-based resistance putty in a randomized controlled 
crossover pilot study. Patients improved hand strength 
and self-perception of occupational performance. Despite 
a large dropout due to personal reasons, lack of motiva-
tion, and fatigue, the study addresses an important issue 
that hand impairment can have on ADL.
Recently, Okkersen et al assessed the effects of cog-
nitive behavioral therapy with optional graded exercise 
therapy in patients with severe fatigue in a single-blind, 
large randomized trial (31). Cognitive behavioral therapy 
increased patients’ capacity for activity and participation, 
compared with standard care alone. 
Intervention specifications for DM are presented in 
Table 4.
Glycogen storage disease
McArdle disease
Table 3. A representation of exercise interventions done in FSHD. Number in parenthesis represents the article reference.
Exercise 
mode/N
Duration Frequency Intensity Improved outcome
Cycling
N = 8
Control group 
N = 7
(17)
12 weeks 5 days/week
35 min/session 
65% VO2max VO2max, workload, 
and ADL
Cycling + 
post exercise 
protein-
carbohydrate 
supplement 
N = 18
Cycling + 
placebo 
supplement 
N = 13 
Control group 
N = 10
(18)
12 weeks
12 months F/U
3 days/week 
15 min/session week 1
20 min/session week 2
30 min/session from week 3
70% VO2max 6MWT, workload, 
fitness, and SF-36
u
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Exercise 
mode/N
Duration Frequency Intensity Improved outcome
Cycling 
N = 20 
Cognitive-
behavioral 
therapy  
N = 13
Usual care 
N = 24
(19)
16 weeks 3 days/week (2 days at home and 1 
day supervised) 
38 min/session, including a 5 min 
warm up 30 min exercise 3 min cool 
down
Cognitive-behavioral therapy 
comprised of 6 modules:
Dysfunctional cognitions regarding 
fatigue, activity, pain, or other 
symptoms; fatigue catastrophizing 
(a cognitive process that involves 
negative outcome expectations 
from fatigue); dysregulation of sleep 
or activity; poor social support; 
and negative social interactions. 
Both aerobic exercise therapy and 
cognitive behavioral therapy were 
found to be superior to usual care in 
reducing fatigue
50-65% HRmax
12-14 RPE (Borg 
Scale)
Fatigue
Cycling 
N = 8 
Control group
N = 8
(20)
24 weeks 3 days/week
35 min/session 
2 sessions at 
60% max aerobic 
power
1 session interval 
training 40% and 
80% max aerobic 
power
VO2max, 6MWT, and 
fatigue severity 
scale
Strength 
N = 34
Control 
N = 31 
(21)
52 weeks 3 days/week 10 RM, 2 sets x 
5-10 reps Dynamic 
and isometric 
strength: 
Elbow flexion 
and ankle dorsal 
flexion
1RM, and dynamic 
elbow flexor 
strength
HIT: 
Cycling 
N = 6
UC 
N = 7
Control group
N = 7
(22)
8 weeks 
supervised 
8 weeks with 
unsupervised 
for all. 
21 min/session, including an 8-min 
warm-up and two sets of
5-min HIT with 3-min break at very low 
intensity.
3 days/week 
Each minute 
of HIT was 
performed at three
different work 
intensities: 30 s of 
easy pedaling (low
intensity), 20 s of 
hard work (middle 
high intensity), 
and
10 s of all-out, 
maximal intensity
VO2max and 
workload
NMES
N = 9
(23)
5 months 5 days/week
20 min/session
Rise time 1.5s; 
steady tetanic 
stimulation
time: 6s; fall time 
1.5s
Pain, fatigue, 
shoulder flexion 
strength, knee 
extension strength, 
and 6MWT
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Aerobic exercise
Haller et al. (32) found that patients generally benefit-
ted from moderate aerobic training. However, one patient 
had elevated CK levels the first two weeks of intervention, 
which stabilized thereafter, and another patient had elevat-
ed CK levels during week 8, possibly due to unusual phys-
ical exertion at home, according to author reporting. Aside 
from the two patients, CK levels remained stable, indicat-
ing that exercise did not provoke muscle injury. Porcelli 
et al. (33) found that home-based aerobic training also in-
creased fitness in patients with McArdle disease. However, 
patients did not feel any benefits from the exercise nor did 
the intervention increase their habitual ADL. 
Maté-Munoz et al.  (34) examined the acute and 
chronic responses to exercise in patients with McArdle 
disease. The acute response consisted of two tests (see 
Table  5). Ten patients underwent an 8-month long su-
pervised moderate aerobic exercise program to test the 
chronic exercise response. Most patients chose walking 
as preferred exercise mode. Both the acute and chron-
ic group showed an increase in fitness and ventilatory 
threshold. No adverse events or discomfort were reported 
and CK levels remained stable post exercise. 
From the presented studies, it appears that regular ex-
ercise may lead to physiological adaptations that increase 
oxidative and work capacity in patients with McArdle 
disease. 
A case study reported the effects of a 6-week strength 
training program. The results from the low weight and 
high repetition training program lowered the patient’s dis-
ease severity class  (35). The training closely resembles 
aerobic training intensity, which could explain the bene-
fits obtained from the training. Intervention specifications 
for McArdle disease are presented in Table 5.
Pompe disease
Combined aerobic and strength exercise
Muscle strength and functional capacity was shown 
to increase with moderate aerobic and strength exer-
cise training in patients with late-onset Pompe disease 
receiving enzyme replacement therapy  (36). Despite 
small sample size, the results are encouraging. Van den 
Berg et al evaluated the safety and efficacy of moderate 
endurance, strength, and core stability training (37). Af-
ter 12-weeks, core stability, muscle strength in hip and 
shoulder, and functional capacity improved. The first 
week of training, two patients had elevated plasma CK 
levels, experienced muscle pain, and fatigue. During the 
second week, CK levels dropped to their normal range, 
and fatigue and pain diminished greatly. Both patients 
Table 4. A representation of exercise interventions done in DM. Number in parenthesis represents the article reference.
Exercise mode/N Duration Frequency Intensity Improved 
outcome
Cycling
N = 9
(24)
12 weeks 5 days/week
35 min/session
65% of VO2max Self-reported 
improvements in 
ADL, VO2max, and 
workload
Strength
N = 27
Control group
N =14
(25)
12 weeks 3 days/week Knee extension: 30-40% of max, 3 sets x 
4-8 reps
Elbow flexion 10-20% of max, 3 sets x 4-8 
reps
Hand grip: 100%, 3 sets x 4 reps
Increase in strength
Strength
N = 6
(26)
12 weeks 3 days/week Knee extension
60-80% of 1RM, 3 x 10 reps
1RM
Strength
N = 33 
(27)
24 weeks 3 days/week
30 min/session
Knee extension and flexion, hip extension 
and abduction
60-80% of 1RM 
Week 1-8: 60% of 1RM, 3 sets x 25 reps 
Week 9-16: 70% of 1RM, 3 sets x 15 reps
Week 17-24: 80% of 1RM, 3 sets x 10 reps
Neither positive or 
negative effects of 
the training
u
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continued the training. This study indicates that a com-
bination of aerobic, resistance and core stability training 
can be performed safely in patients with Pompe disease. 
However, when combining different modes of exercise, 
it can be challenging to determine which exercise im-
proved which outcome. 
In 2007, a published paper evaluated whether the 
adherence to nutrition and exercise therapy could slow 
the deterioration of muscle function (38). Of the 34 pa-
tients included, 22 were fully compliant with nutrition 
and exercise therapy. Patients demonstrated a slowing of 
their deterioration in muscle function and some showed 
improvement in their Walton score. Whether continued 
compliance with nutrition and exercise therapy slows dis-
ease progression long term, and if nutrition and exercise 
therapy can minimize muscle deterioration at symptom 
onset should be further explored. 
Moderate intensity exercise appears to have an ad-
juvant effect on patients with Pompe disease and regular 
exercise is recommended.
Other exercise modalities 
Side alternating vibration training (SAVT) is me-
chanical oscillation applied while standing on a vibrating 
platform. The oscillation is characterized by amplitude 
and frequency which determine the intensity of the work 
performed. One patient with Pompe underwent SAVT, 
and after 15 weeks of SAVT the patient showed an im-
Exercise mode/N Duration Frequency Intensity Improved 
outcome
Strength 
N = 33 
(28)
24 weeks 3 days/week Knee extension and flexion, hip extension 
and abduction
60-80% of 1RM 
Week 1-8: 60% of 1RM, 3 sets x 25 reps 
Week 9-16: 70% of 1RM, 3 sets x 15 reps
Week 17-24: 80% of 1RM, 3 sets x 10 reps
Neither positive or 
negative effects of 
the training
Functional 
electrical 
stimulation 
induced cycling 
N = 4
Strength and 
cycling
N = 4
(29)
3 weeks
6 weeks
Functional 
electrical 
stimulation:
30 minutes 
5 days/week
Strength:
5 days/week 
30 min/session
Cycling: 
5days/week
30 min/session
Functional electrical stimulation:
Frequency of 30 Hz (pulse width, 200 
µseconds)
Strength training:
Knee extension, knee flexion, ankle 
dorsiflexion, ankle plantarflexion 
2 sets x 10 reps at 60% of 1RM (week 1-3)
2 sets x 5 reps at 80% of 1RM (week 4-6)
Cycling:
60% of HRmax
MRC, 6MWT and 
10MWT
Hand-training
Cross-over study 
N = 9 Group A
N = 4 Group B
(30)
12 weeks of 
training
12 weeks of 
wash out
12 weeks of 
control
Minimum of 27 
sessions
60 min/session 
 
Week 1-4: 1 set x 10 reps
Week 5-8: 2 sets x 10 reps 
Week 9-12: 3 sets x 10 reps 
Isolated finger movement:
1 set x 3 reps, 2 sets x 3 reps, 3 sets x 3 
reps
Wrist extension/flexion
Finger extension/flexion
Isolated finger extension/flexion
Thumb extension/flexion
Finger adduction/abduction
Stretching wrist in flexion/flexion
Handgrip, pinch, 
and wrist strength
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provement in functional capacity and strength (39). The 
patient reported muscle soreness, stiffness, and aches in 
legs, twitching while at rest, cramping, and fatigue. De-
spite the discomfort, her level of activity did not change. 
The level of safety of SAVT is questionable and should be 
the subject for further exploration. 
Intervention specifications for Pompe disease are 
presented in Table 6. 
Table 5. A representation of exercise interventions done in McArdle disease. Number in parenthesis represents the 
article reference.
Exercise mode/N Duration Frequency Intensity Improved 
outcome
Cycling
N = 8
(32)
14 weeks Week 1-7:
4 days/week
30 min/session
Week 8-14: 
4 days/week
40 min/session
60-70% HRmax Oxidative and 
work capacity
Electromagnetically 
braked cycling 
N = 7 
(33)
12 weeks 4 days/week
60-90 min/session
65-70% of HRmax Aerobic 
capacity and 
work load
Acute: 
Cycling
(strictly monitored)
N = 46
Control group 
N = 46
Chronic:
Walking or cycling
N = 9
(34)
Acute:
1 day
Chronic:
8 months
1 day
5 days/week
60 min/session 
1. Workload increased with 10 Watt/
min until exhaustion, starting at 10 
Watt
2. A 12-minute constant-load test at 
the power output reaching ventilatory 
threshold on a cycle
The two tests were separated by 
a 10-minute active rest period 
(freewheel pedaling)
75 g sucrose beverage prior to test
60% of HRmax
Complex carbs 1 hour before exercise 
and simple carbs during exercise
Aerobic 
capacity, 
peak power 
output, and 
ventilatory 
threshold
Strength 
N = 1
(35)
6 weeks 2 days/week
Up to 60 min/session
65-70% of 1RM
10-minute warm-up consisting of 5 
minutes of light-intensity dynamic 
exercise (on a cycle ergometer or 
rowing ergometer), followed by 5 
minutes of mobilization exercisesand 
body weight exercises (eg, 
shoulder shrugs and rotations, arm 
elevations, changing squat stance, 
walkinglunges, push-ups on the wall).
Benchpress with free weights, 
multipower squat, shoulder press, 
armcurls and elbow extensions 
with dumbbells, lateral pulldown, 
abdominal crunches, and low back 
extensions. 
2-3 sets x 10-15 reps
Patient 
changed to a 
lower disease 
severity class
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Mitochondrial myopathy
Aerobic exercise
The aspect of training patients with mitochondri-
al disease is somewhat different from other myopathies 
in that patients experience a metabolic bottleneck in the 
mitochondrial respiratory chain function. Taivassalo et al 
found that aerobic capacity increased with moderate in-
tensity exercise on a treadmill. Fatigue and tolerance to 
daily activities also improved, and lactate concentration 
decreased (40). In 6 of the 10 participating patients, CK 
levels rose slightly, but not to a level indicating significant 
muscle damage. These findings are in agreement with a 
study examining the effects of moderate intensity cycling 
exercise (41). Similar findings were reported by Sicilia-
no et al.  (42)  (43) showing a decreased lactate concen-
tration, improved SF-36, and improved muscle oxidative 
metabolism with aerobic training. Jeppesen et al.  (44) 
demonstrated that moderate aerobic training was safe and 
improved aerobic capacity. No training-induced increas-
es in plasma CK levels were observed. Trenell et al also 
found beneficial effects from moderate aerobic training 
including improvement in functional abilities (45). Jeppe-
sen et al. (46) investigated the effects of short- and long-
term moderate home-based endurance exercise. Exercise 
increased oxidative capacity and peak work load. These 
improvements were sustained after 12 months of exer-
cise. No training-induced CK elevation was observed and 
patients reported feeling a physical improvement. The ef-
fects of moderate intensity cycling and moderate intensi-
ty arm strength exercise revealed an increase in functional 
capacity and muscle strength (47). The training effect was 
also reflected as improvements in symptoms. To counter-
act limitations in the oxygen transport pathway, exercise 
seems to be a promising therapeutic avenue for persons 
affected by mitochondrial myopathy (48). 
Other exercise modalities
The effects of SAVT was considered safe and pa-
tients showed some increase in muscle power (49). The 
presented studies indicate that moderate intensity aerobic 
exercise is safe and can improve physical capabilities in 
patients with mitochondrial myopathy. 
Intervention specifications for mitochondrial myopa-
thies are presented in Table 7.
Motor neuron diseases
Spinal and bulbar muscular atrophy (SBMA, Kennedy 
disease)
Aerobic exercise 
Moderate aerobic training was examined by Preisler 
et al.  (50). By week 5 of the intervention three patients 
found it challenging to exercise for 30 minutes due to fa-
tigue or not feeling well recovered in between training 
sessions. Patients did not experience any change in their 
daily physical activity, and one patient felt daily phys-
ical activity worsened post intervention. Fatigue level 
increased in seven patients and only one patient experi-
enced improvement. A few patients did feel an increase 
in endurance, strength, and the distance they were able to 
walk, while others didn’t experience physical improve-
ments or reported a worsening in endurance, strength, 
and walking distance. No CK level elevation occurred in 
seven of the 8 patients, one patient was asked to exercise 
with a lower frequency.
Other exercise modalities 
High-intensity training improved fitness and work-
load in 8 patients after 8 weeks of training  (51). One 
patient was excluded due to lack of compliance and one 
patient did not wish to continue for personal reasons. No 
rise in CK levels occurred after 8 and 16 weeks of train-
ing. Self-rated muscle fatigue, muscle pain, and activity 
level remained the same throughout the training period. 
Patients expressed an interest in HIT. High-intensity 
training seems to be a beneficial alternative in compari-
son to moderate aerobic training, likely because neuronal 
fatigue due to short duration of exercise is avoided. 
Bulbar involvement in patients with SBMA can 
cause dysphagia and swallowing difficulties. Effects of 
head lift exercises in swallowing showed an improvement 
in functional scores for oral dysphagia, indicating that 
head lifting exercise may factor into improving swallow-
ing  (52). Any clinical relevance should be integrated in 
the clinic with caution, considering the small sample size 
of the study. 
Shrader et al. examined the effects of functional exer-
cise  (53). The authors concluded that functional exercise 
is well tolerated, however, they did not find any functional 
changes and a modest increase in CK levels was observed. 
High-intensity training is recommended in patients 
with SBMA because it has the best efficacy and is pre-
ferred by patients. Intervention specifications for SBMA 
are presented in Table 8.
Spinal muscular atrophy
Aerobic exercise
Effects of arm cycling in patients with SMA type II 
showed no adverse events during or after exercise. There 
was an increase in their cycling distances and durations, 
but no improvements were observed in Hammersmith 
Functional Motor Scale (HFMS) (54). 
Effects of home-based cycling was investigated by 
Madsen et al in 8 ambulatory patients with SMA type 
III (55). One patient discontinued the intervention due to 
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Table 6. A representation of exercise interventions done in Pompe disease. Number in parenthesis represents the 
article reference.
Exercise 
mode/N
Duration Frequesncy Intensity Improved outcome
Cycling and 
Strength
N = 5
(36)
20 weeks 3 days/week
10-15 min/session 
(week 1-3) 
30 min/session (week 
4-20)
Week 1-3:
Cycling at level 1-2
Strength: ¼ squat, leg curl, knee 
raise, push-ups against a wall, back 
extensions, as well as sit ups, ¼ 
overhead press, elbow extensions and 
elbow curl
50% of 1RM, 2 sets x 10 reps
Week 4-20:
Cycling at level 2-4
50% of 1RM, 3 sets x 10 reps
Strength increased 
and 6MWT 
Cycling, 
strength, and 
core stability
N = 23
(37)
12 weeks 3 days/week 60% of VO2max
70% of 4RM
One session consisted of:
5 minutes warm up 
15 minutes cycling
Shoulder extension, flexion and 
abduction, elbow flexion, knee extension 
and flexion, hip flexion, abduction and 
adduction: 3 sets x 15-20 reps 
15 minutes cycling 
3 x 30 seconds: Abdominal bridge, side 
bridge, back bridge
Climb 4 steps, 
muscle, strength in 
shoulder abductors 
and hip flexors, 
6MWT, rise from 
supine to standing, 
workload, VO2max, 
ventilatory threshold, 
and core stability
High-protein 
and low-
carbohydrate 
nutrition and 
exercise 
therapy 
Treadmill and 
upper body 
ergometer
N = 34 (22 
complied 
with nutrition 
and exercise 
therapy
(38)
2y-10y Daily
45 min/session on 
treadmill
10-15 min/session 
upper body 
ergometer 
Not exceed RPE of 11–12 Slowing of 
deterioration in 
muscle function
SAVT
N = 1
(39)
15 weeks One cycle: 
60 seconds 
vibration-on
60 seconds 
vibration-off
Vibration frequency 5 Hz, progressing to 
20 Hz by week 11, and continuing at 20 
Hz to week 15 
Starting with two cycles initially, 
progressing to four cycles by week 11 
and continuing with four cycles to week 
15.
Improved strength 
and 6MWT
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Table 7. A representation of exercise interventions done in Mitochondrial myopathy. Number in parenthesis represents 
the reference.
Exercise mode/N Duration Frequency Intensity Improved 
outcome
Treadmill
N = 10
(40)
8 weeks 3-4 days/week
20-30 min/session
60-80% HRmax
Not exceed 15 RPE 
Aerobic 
capacity, lactate 
concentrations 
decreased,
fatigue 
decreased, and 
tolerance to 
daily activities 
Cycling
N = 8
(41)
14 weeks
49 sessions
Week 1-7:
3 days/week 
30 min/session 
Week 8-14
4 days/week
40 min/session
70-80% HRmax SF-36 and 
aerobic peak 
capacity
Cycling
N = 7
Control group  
N = 12
(42)
10 weeks Week 1-5:
30 min/session
Week 6-10:
45 min/session
Max 70% HRmax
60-70 revolution (paddling)/min
Max 70% of predicted normal 
maximum power output
Partially 
reverting 
oxidative stress
Cycling
N = 12
Control group N = 4
(43)
10 weeks Week 1-5:
Every other day
30 min/session
Week 6-10:
Every other day
45 min/session
Max 70% HRmax
60–70 revolution (paddling)/
min
60-70% of predicted normal 
maximum power output
Lactate 
concentration 
and
muscle 
oxidative 
metabolism
Cycling 
N = 20 
Control group 
N = 13
(44)
12 weeks 50 sessions in total
30 min/session
65-75% HRmax Oxidative
capacity, 
VO2max, and 
workload
Cycling
N = 10
Control group 
N = 10
(45)
12 weeks 3 days/week
30 min/session
70-80% HRmax Mitochondrial 
function
and functional 
ability 
Cycling
N = 4
(46)
Initial: 12 weeks
Deconditioning: 
3-12 months
Second training 
phase: 12 
months
5 days/week
3 days/week
30 min/session
70% of VO2max Oxidative 
capacity and 
workload
u
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severe fatigue and one patient due to difficulty using the 
cycle independently. Among the remaining patients, the 
authors found that the exercise was safe. However, pa-
tients reported either no change or an increase in fatigue, 
and no improvements in physical function.
Strength exercise
Submaximal resistance training is found to be well 
tolerated with some strength improvements with no 
study-related adverse events occurred (56).
Combined aerobic and strength
Moderate intensity cycling and strengthening exer-
cise was well tolerated among all patients participating 
in a single blind randomized controlled clinical (57). The 
authors reported a large number of falls among the pa-
tients, potentially related to fatigue following training. 
Reporting of muscle soreness and low back pain was also 
documented. The most notable change was an increase in 
oxidative capacity. No harmful impact was observed on 
motor function, strength, and fatigue. 
In a recent Cochrane review the authors conclude that 
it is uncertain whether combined strength and aerobic ex-
ercise is beneficial or harmful in people with SMA (58). 
Further research is needed to understand the rather blunt-
ed response from exercise. High-intensity training could 
be a better exercise modality in SMA patients, as it has 
been shown to be in SBMA. Intervention specifications 
for SMA are presented in Table 9.
Conclusions
There is considerable amount of evidence indicating 
that moderate intensity aerobic- and strength exercise is 
advantageous for patients with muscle diseases, with-
out causing harmful muscle damage. Exercise should be 
planned carefully and be well monitored, and should be 
performed within the patients’ limitations. Extreme fa-
tigue and muscle pain, during or after exercise is indic-
ative of negative response to exercise, and intensity and 
frequency should be reconsidered.
In contrast, motor neuron diseases show different 
outcomes from exercise. Exercise has a rather blunted re-
sponse in these patients. One possible explanation could 
Exercise mode/N Duration Frequency Intensity Improved 
outcome
Cycling and strength 
N = 10
Control group 
N = 10 
(47)
12 weeks 3 days/week
60 min/session
70% of peak work load 
Shoulder press, chest press, 
bicep curl
50% of 1RM 
1 set x 10-15 reps (first two 
weeks)
From week 3: 2 or 3 sets x 
10-15 reps (according to 
tolerance)
Oxygen uptake, 
work output, 
endurance, 
shuttle walking 
test, muscle 
strength, NHP, 
and clinical 
symptoms
SAVT
N = 7
(49)
12 weeks 3 days/week 5-20 Hz (steady increase within 
2 weeks) 
Week 1:
5 Hz 1 min on, 1 min off, 1 min 
on 
Week 2:
10 Hz 2 min on, 1 min off, 1 
min on 
Week 3: 
15 Hz 2 min on, 1 min off, 1 
min on 
Week 4: 
20 Hz 2 min on, 1 min off, 1 
min on 
Week 5–12:
20 Hz 2 min on, 1 min off, 2 
min on
Some increase 
in muscle force 
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be that they reach a level of fatigue quicker due to larger 
motor units that need to fire more frequently, which may 
cause a neural fatigue, which these patients experience 
after long-lasting exercise. In these patients, high-inten-
sity training seems safe and may be a promising exercise 
method which allows the patient to train effectively. 
The presented studies include ambulatory patients. 
In recent years, a few studies have explored the effects 
of exercise using assisted devices. The effects of exercise 
using assistive devices should be further explored in very 
weak and non-ambulatory and wheelchair bound patients.
In addition, it is imperative to set a goal for the exer-
cise in order to obtain clinical relevance, and also deter-
mine the appropriateness of training in isolated muscle 
groups vs. whole-body. Future research should direct the 
focus on determining duration, frequency, and intensity 
in order to create an exercise guideline that clinicians and 
patients can use. 
One of the challenges in studying exercise in mus-
cle and lower motor neuron diseases is that the diseases 
are rare and heterogeneous and one type of exercise may 
not work for everyone. Furthermore, it can be difficult 
to recruit a sufficient number of subjects for RCTs and 
examine the long- term effects of exercise, because of the 
rareness of the diseases. Lastly, quality of life and social 
aspects of exercise, as well as motivation and compliance 
needs more emphasis in trials on exercise therapy in mus-
cle and motor neuron diseases. 
Table 8. A representation of exercise interventions done in SMBA. Number in parenthesis represents the article refer-
ence.
Exercise 
mode/N
Duration Frequency Intensity Improved out-
come
Cycling
N = 8
(50)
12 weeks Week 1-2:
2 days/week
Week 3-4:
3 days/week
Week 5-12:
5 days/week
30 min/session 
65-70% VO2max Workload and 
citrate synthase
Cycling
N = 8
(51)
8 weeks of 
HIT and 8 
weeks of 
self-training
3 days/week 2×5-min exercise periods with 1-min 
cyclic blocks of intermittent maximal 
intensity
VO2max, workload, 
and 6MWT
Head lift 
(Shaker 
exercise)
N = 6
(52)
6 weeks 6 times a day for 6 
weeks
Component 1: 1 min isometric, 1 min 
rest x 3
Component 2: 30 seconds of isokinetic
Functional scores 
for oral dysphagia
Functional 
exercise
N = 24
Stretching 
N = 26
(53)
12 weeks Week 1+2:
2 days/week
Week 3 - 12:
3 days/week
Weeks 4-6:
3 days/week
Week 7-12:
3 days/week
Trunk sit back, STS, standing squat 
with theraband row, standing lunge 
with theraband, forward reach, double 
limb heel raise, and wall pushup
Week 1+2:
1 set x max reps at 50-70%% of 1RM
Week 3 - 12:
1 set x max reps at 50-70%% of 1RM
Weeks 4-6:
2 sets x max reps at 50-70%% of 1RM 
Week 7-12:
3 sets x max reps at 50-70%% of 1RM
No functional 
changes 
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Abbreviations
ADL = Activities of Daily Living 
BMD = Becker muscular dystrophy 
CK = Creatine Kinase 
DM = Myotonic muscular dystrophy
DMD = Duchenne muscular dystrophy 
F/U = Follow-up
FSHD = Facioscapulohumeral muscular dystrophy
HFMS = Hammersmith Functional Motor Scale 
HIT = High Intensity Training 
HR = Heart rate 
LGMD = Limb-girdle muscular dystrophy
LOIT = Low Intensity Training
Min = Minutes
MRC = Medical Research Council
NHP = Nottingham Health Profile
NMES = Neuromuscular Electrical Stimulation
RCT = Randomized Controlled Trial
Reps = Repetitions
RPE = Rate of Perceived Exertion
SAVT = Side Alternating Vibration Training 
SBMA = Spinal and Bulbar Muscular Atrophy 
SF-36 = 36 Item Short Form Survey 
SMA = Spinal Muscle Atrophy 
SST = Stair Step Test 
STS = Sit-to-Stand
TUG = Timed Up and Go
UC = Usual Care 
VAS = Visual Analog Scale 
VO2max = Maximum volume oxygen consumption
6MWT = Six-Minute Walk Test
1RM = One-repetition maximum
10MWT = 10 Meter Walk Test
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